Search Results 1211-1220 of 3933 for Solid

  1. A Study Of CUFFLESS PHOTOPLETHYSMOGRAPHY - Mayo Clinic

    Subjects with solid dark tattoos on the area where the PPG-based device is attached. Subjects who are unwilling to have their chest hair shaved, if needed ...

  2. Performance Of A Multi-Target Hepatocellular Carcinoma (HCC) Test In Subjects With Increased Risk - Mayo Clinic

    Solid liver nodule >1 cm by ultrasound or elevated AFP (>100 ng/mL) in 12 months preceding the qualifying surveillance imaging visit without subsequent ...

  3. Phase II Study of Bendamustine and Rituximab Plus Venetoclax in Untreated Mantle Cell Lymphoma Over 60 Years of Age (PrE0405) - Mayo Clinic

    - Patients must not have received a prior allogeneic stem cell transplant or solid organ transplant (except for cornea) for any indication. - Patients must ...

  4. Study of Pembrolizumab With Ipilimumab or Placebo in Participants with Untreated Metastatic Non-small Cell Lung Cancer - Mayo Clinic

    Has had an allogeneic tissue/solid organ transplant. Has received a live vaccine within 30 days prior to the first dose of trial treatment. Examples of live ...

  5. Mayo Clinic Transplant Center - Clinical trials

    Trimethoprim-sulfamethoxazole Graded Administration in Oncology, Hematopoietic Stem Cell Transplant, and Solid Organ Transplant Patients with a History of ...

  6. Radiation Therapy in Treating Patients With Extensive Stage Small Cell Lung Cancer - Mayo Clinic

    Radiographic partial or complete response to chemotherapy in ≥ 1 site of disease according to Response Evaluation Criteria in Solid Tumors (RECIST) ...

  7. Publications - Aleksandra Kukla, M.D. - Mayo Clinic

    ... Solid Organ Transplant Consortium. A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant ...

  8. A Study Using a New Drug, Nivolumab, in Combination With Chemotherapy Drugs to Treat a Type of Cancer Called Nasopharyngeal Carcinoma (NPC) - Mayo Clinic

    * Patients who have undergone solid organ or allogeneic hematopoietic transplant at any time * Due to risks of fetal and teratogenic adverse events as seen ...

  9. Risk-Based Therapy in Treating Younger Patients with Newly Diagnosed Liver Cancer - Mayo Clinic

    Patients who have previously received a solid organ transplant are not eligible; Patients who have an uncontrolled infection are not eligible; Females who are ...

  10. Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen - Mayo Clinic

    solid or liquid tumor for ≥ 1 year prior to the start of study treatment and, in the opinion of the Investigator, the disease will not affect participant's ...